Riverside Adds Transplant Connect to InVita Healthcare Technologies Platform
January 18, 2022
The Riverside Company has invested in Transplant Connect, maker of the iTransplant software platform, as an add-on to Riverside’s healthcare software platform InVita Healthcare Technologies. Transplant Connect, founded in 2003 and based in Los Angeles, provides clinical information management, communications, analytics and logistics across the lifecycle of human biologic donation and transplantation.
- Buyers
- The Riverside Company
- Targets
- Transplant Connect
- Platforms
- InVita Healthcare Technologies
- Industry
- Healthcare Services
- Location
- California, United States
- Transaction Type
- Addon
Explore More
Related Acquisitions
-
The Riverside Company Invests in Virtual IT Group
June 21, 2024
IT Services
The Riverside Company has signed a definitive agreement to make an investment in Australian managed service provider Virtual IT Group (VITG). The growth capital will support VITG's platform expansion, organic growth and M&A activity while founder Christian Pacheco remains Managing Director and a significant shareholder.
-
InVita Healthcare Technologies / The Riverside Company Acquire BloodHub
October 6, 2022
Cloud & SaaS
InVita Healthcare Technologies, a portfolio company of The Riverside Company, has acquired BloodHub and folded it into InVita's Blood Management Division. Riverside made the investment as an add-on to its InVita platform to expand InVita's blood- and biologics-focused supply chain and laboratory software capabilities across North America.
-
Riverside-backed InVita Invests in STACS DNA
May 18, 2021
Software
The Riverside Company has invested in STACS DNA as an add-on to its InVita Healthcare Technologies platform; InVita (backed by Riverside) will integrate STACS DNA's sample-tracking and lab management software into its suite for complex medical environments. STACS DNA, headquartered in Ottawa, Ontario, provides forensic and healthcare sample-tracking solutions used by customers such as the FBI, RCMP and Merck to improve laboratory workflows, compliance and patient safety.
-
Red Nucleus / Riverside Acquire INVIVO Communications
September 30, 2020
Healthcare Services
Red Nucleus, the life-sciences learning and performance platform backed by The Riverside Company, acquired Toronto-based INVIVO Communications, a digital scientific communications agency. The deal is an add-on to Riverside's Red Nucleus platform, expanding RN's medical communications and digital scientific communications capabilities; the combined business now totals 360+ employees across seven locations.
-
The Riverside Company Invests in Champion Healthcare Technologies and Combines It with HemaTerra
June 6, 2019
Cloud & SaaS
The Riverside Company has invested in Champion Healthcare Technologies and combined it with HemaTerra Technologies (a company Riverside invested in earlier) to form a leading medical specialty software business. The combined firm will provide SaaS solutions for implant lifecycle management and blood/plasma collection operations, serving over 500 hospitals and numerous independent blood and plasma centers across the United States.
-
The Riverside Company Invests in HemaTerra Technologies
April 18, 2019
Cloud & SaaS
The Riverside Company has invested in HemaTerra Technologies, a provider of cloud-based SaaS solutions for blood and plasma collection centers, hospitals and related healthcare organizations. Riverside said it will invest in product development, sales and marketing, and strategic partnerships to scale HemaTerra's offerings and support continued growth.
Build a buyer list for your deal
Find active buyers from recent acquisition patterns and move straight into outreach.